Literature DB >> 31758392

miR-663b promotes colorectal cancer progression by activating Ras/Raf signaling through downregulation of TNK1.

Sen Hong1, Zhenkun Yan2, Helei Wang3, Lei Ding4, Yumei Song5, Miaomiao Bi6.   

Abstract

MiR-663b has been demonstrated to be abnormally expressed in several cancer types and was involved in the progression of cancer. Although overexpression of miR-663b in colorectal cancer was observed, the role of miR-663b in colorectal cancer cells has not been identified yet. In this study, we analyzed expression of miR-663b in colorectal tumors and explored the molecular mechanism of miR-663b in colorectal cancer cells. MiR-663b was significantly overexpressed in colorectal tumors and cell lines. Downregulation of miR-663b inhibited cell proliferation and sphere forming ability in colorectal cancer cells. In addition, miR-663b downregulation inactivated Ras/Raf signaling activity and subsequently decreased YAP1 and CD44 expression in colorectal cancer cells. Using TargetScan software, TNK1, a negative regulator of Ras/Raf signaling, was predicted to be a target gene of miR-663b. Western blotting and RT-qPCR showed that TNK1 expression was negatively regulated by miR-663b. In addition, the direct binding of miR-663b to TNK1 mRNA was proved by dual luciferase reporter assay. Furthermore, downregulation of miR-663b inhibited colorectal cancer cell proliferation and stemness, which was reversed after siRNA-mediated silencing of TNK1. In conclusion, the current study revealed a pivotal role of miR-663b in the progression of colorectal cancer.

Entities:  

Keywords:  Colorectal cancer; TNK1; microR-663b

Mesh:

Substances:

Year:  2019        PMID: 31758392     DOI: 10.1007/s13577-019-00294-w

Source DB:  PubMed          Journal:  Hum Cell        ISSN: 0914-7470            Impact factor:   4.174


  35 in total

Review 1.  Targeting EGFR and RAS/RAF Signaling in the Treatment of Metastatic Colorectal Cancer: From Current Treatment Strategies to Future Perspectives.

Authors:  Takuro Mizukami; Naoki Izawa; Takako Eguchi Nakajima; Yu Sunakawa
Journal:  Drugs       Date:  2019-04       Impact factor: 9.546

2.  MicroRNA‑663b downregulation inhibits proliferation and induces apoptosis in bladder cancer cells by targeting TUSC2.

Authors:  Jianying Chen; Bo Song; Guangqi Kong
Journal:  Mol Med Rep       Date:  2019-03-14       Impact factor: 2.952

Review 3.  Identification and consequences of miRNA-target interactions--beyond repression of gene expression.

Authors:  Jean Hausser; Mihaela Zavolan
Journal:  Nat Rev Genet       Date:  2014-07-15       Impact factor: 53.242

4.  Epigenetic modification of miR-663 controls mitochondria-to-nucleus retrograde signaling and tumor progression.

Authors:  Trevor Carden; Bhupendra Singh; Ved Mooga; Prachi Bajpai; Keshav K Singh
Journal:  J Biol Chem       Date:  2017-10-24       Impact factor: 5.157

5.  Kos1, a nonreceptor tyrosine kinase that suppresses Ras signaling.

Authors:  Kishalay Hoare; Sarasija Hoare; Orla M Smith; Grace Kalmaz; Donald Small; W Stratford May
Journal:  Oncogene       Date:  2003-06-05       Impact factor: 9.867

6.  A link between ras and metastatic behavior of tumor cells: ras induces CD44 promoter activity and leads to low-level expression of metastasis-specific variants of CD44 in CREF cells.

Authors:  M Hofmann; W Rudy; U Günthert; S G Zimmer; V Zawadzki; M Zöller; R B Lichtner; P Herrlich; H Ponta
Journal:  Cancer Res       Date:  1993-04-01       Impact factor: 12.701

7.  MicroRNA-663b promotes cell proliferation and epithelial mesenchymal transition by directly targeting SMAD7 in nasopharyngeal carcinoma.

Authors:  Meirong Wang; Min Jia; Kun Yuan
Journal:  Exp Ther Med       Date:  2018-08-07       Impact factor: 2.447

8.  miR-663b promotes tumor cell proliferation, migration and invasion in nasopharyngeal carcinoma through targeting TUSC2.

Authors:  Shaoqiang Liang; Ning Zhang; Yanming Deng; Lusi Chen; Yang Zhang; Zhenhe Zheng; Weijun Luo; Zhiqian Lv; Shaoen Li; Tao Xu
Journal:  Exp Ther Med       Date:  2017-06-14       Impact factor: 2.447

9.  miR-663 sustains NSCLC by inhibiting mitochondrial outer membrane permeabilization (MOMP) through PUMA/BBC3 and BTG2.

Authors:  Micol E Fiori; Lidia Villanova; Chiara Barbini; Maria Laura De Angelis; Ruggero De Maria
Journal:  Cell Death Dis       Date:  2018-01-19       Impact factor: 8.469

10.  miR-663 overexpression induced by endoplasmic reticulum stress modulates hepatocellular carcinoma cell apoptosis via transforming growth factor beta 1.

Authors:  Yawei Huang; Jiatao Liu; Lulu Fan; Fang Wang; Hanqing Yu; Wei Wei; Guoping Sun
Journal:  Onco Targets Ther       Date:  2016-03-17       Impact factor: 4.147

View more
  7 in total

1.  Polymorphism rs11867353 of Tyrosine Kinase Non-Receptor 1 (TNK1) Gene Is a Novel Genetic Marker for Alzheimer's Disease.

Authors:  Tomáš Zeman; Vladimir J Balcar; Kamila Cahová; Jana Janoutová; Vladimír Janout; Jan Lochman; Omar Šerý
Journal:  Mol Neurobiol       Date:  2020-10-18       Impact factor: 5.590

2.  Tanshinone IIA regulates microRNA‑125b/foxp3/caspase‑1 signaling and inhibits cell viability of nasopharyngeal carcinoma.

Authors:  Youhu Wang; Wenyao Jin; Junbo Wang
Journal:  Mol Med Rep       Date:  2021-03-24       Impact factor: 2.952

3.  Cervical cancer-derived exosomal miR-663b promotes angiogenesis by inhibiting vinculin expression in vascular endothelial cells.

Authors:  Xuewu You; Wenxiong Sun; Ying Wang; Xiaoli Liu; Aihong Wang; Lu Liu; Sai Han; Yu Sun; Junhua Zhang; Lingyu Guo; Youzhong Zhang
Journal:  Cancer Cell Int       Date:  2021-12-19       Impact factor: 5.722

4.  Pharmacoepigenomics circuits induced by a novel retinoid-polyamine conjugate in human immortalized keratinocytes.

Authors:  Katerina Grafanaki; Ilias Skeparnias; Christos K Kontos; Dimitrios Anastasakis; Aigli Korfiati; George Kyriakopoulos; Konstantinos Theofilatos; Seferina Mavroudi; George Magoulas; Dionissios Papaioannou; Andreas Scorilas; Constantinos Stathopoulos; Denis Drainas
Journal:  Pharmacogenomics J       Date:  2021-06-18       Impact factor: 3.550

5.  A Novel Putative Role of TNK1 in Atherosclerotic Inflammation Implicating the Tyk2/STAT1 Pathway.

Authors:  Mei-Hua Bao; Qiao-Li Lv; Hai-Gang Li; Yi-Wen Zhang; Bao-Feng Xu; Bin-Sheng He
Journal:  Mediators Inflamm       Date:  2020-07-10       Impact factor: 4.711

6.  Thirty-Eight-Negative Kinase 1 Is a Mediator of Acute Kidney Injury in Experimental and Clinical Traumatic Hemorrhagic Shock.

Authors:  Rebecca Halbgebauer; Ebru Karasu; Christian K Braun; Annette Palmer; Sonja Braumüller; Anke Schultze; Fabian Schäfer; Sarah Bückle; Alica Eigner; Ulrich Wachter; Peter Radermacher; Ranillo R G Resuello; Joel V Tuplano; Kristina Nilsson Ekdahl; Bo Nilsson; Milena Armacki; Alexander Kleger; Thomas Seufferlein; Miriam Kalbitz; Florian Gebhard; John D Lambris; Martijn van Griensven; Markus Huber-Lang
Journal:  Front Immunol       Date:  2020-08-26       Impact factor: 7.561

7.  Comprehensive Bioinformatics Analysis of Lipopolysaccharide-Induced Altered Autophagy in Acute Lung Injury and Construction of Underlying Competing Endogenous RNA Regulatory Mechanism.

Authors:  Jian-Yu Liu; Ying-Xiao Jiang; Meng-Yu Zhang; Chen Huo; Yi-Can Yang; Xiu-Li Ji; Yi-Qing Qu
Journal:  Biomed Res Int       Date:  2021-10-21       Impact factor: 3.411

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.